-
专业包装 正品保证
-
快乐服务 售后无忧
-
会员特权 优惠不断
-
个人信息 严格保护
| 别名: | TNFRSF13B|TACI|CD267|CVID|CD267 antigen|CVID2|Transmembrane activator and CAML interactor|tumor necrosis factor receptor | ||
|---|---|---|---|
| 检测范围: | 0.313-20ng/ml | ||
| 灵敏度: | 0.188ng/ml | ||
| 种属: | Human | ||
| 储存条件: | 2-8℃ | ||
|
| 货号 | 规格 | 可用库存 | 销售价(RMB) | 您的折扣价(RMB) | 购买数量 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZY0305EH-96T | 96T | 现货 | 1880 | ||||||||
| 熔点: | |
|---|---|
| 密度: | |
| 储存条件: | 2-8℃ |
Human (TNFRSF13B/TACI)ELISA Kit
Matrices listed below were spiked with certain level of TNFRSF13B/TACI and the recovery rates were calculated by comparing the measured value to the expected amount of TNFRSF13B/TACI in samples.
| Matrix | Recovery range(%) | Average(%) |
|---|---|---|
| serum(n=5) | 86-98 | 93 |
| EDTA plasma(n=5) | 85-105 | 95 |
| heparin plasma(n=5) | 89-103 | 97 |
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of TNFRSF13B/TACI and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 90-98% | 87-104% | 85-105% | 92-102% |
| EDTA plasma(n=5) | 85-100% | 86-100% | 85-97% | 86-95% |
| heparin plasma(n=5) | 82-100% | 80-97% | 82-99% | 83-98% |
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
